Prot #BTTC11-02: NU MD12C01: Phase I/II Adaptive Randomized Trial of Bevacizumab versus Bevacizumab plus Vorinostat in Adults with Recurrent Glioblastoma

  • Raizer, Jeffrey J (PD/PI)

Project: Research project

Project Details

Effective start/end date2/11/132/11/16


  • University of Texas M. D. Anderson Cancer Center (Prot #BTTC11-02: NU MD12C01 // Prot #BTTC11-02: NU MD12C01)
  • Merck Sharp & Dohme Corp. and Genentech, Inc. (Prot #BTTC11-02: NU MD12C01 // Prot #BTTC11-02: NU MD12C01)